A Functional Magnetic Resonance Imaging (fMRI) Study in Overweight and Obese Men (0000-103)

NCT00914212 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: Placebo
DRUG: Comparator: sibutramine

Sponsor

Merck Sharp & Dohme LLC